• Aster aims for the hospital to begin its operations in 2024-25 

Dubai : With an aim to increase its focus and growth in India, Aster DM Healthcare, one of the largest integrated healthcare providers in GCC & India, is strengthening its footing in the country by signing a 30-years lease agreement to set up its sixth hospital in the state of Kerala, adding to existing 14 hospitals in India. The hospital is being set up by Malabar Institute of Medical Sciences (MIMS) Limited, a material subsidiary of Aster DM Healthcare Ltd. and will be situated in the Kasaragod district of Kerala, catering to patients from Malabar and Southern Karnataka. On behalf of Aster, the agreement was signed by Mr. Farhan Yasin, Regional Director, Aster Kerala, and Oman Clusters.

An initial investment of around Rs. 140 crores have been earmarked for the new facility, which will include a 200-bed comprehensive tertiary care facility, with the option of expanding to a quaternary care facility in the future. The new Aster Hospital is expected to begin operations in 2024-25, making quality healthcare more accessible & affordable for patients in the region who will no longer need to travel to Mangalore to receive quality healthcare.

As the first tertiary hospital in Kasaragod district, the upcoming hospital will provide 24x7 emergency and critical care as well as super specialities like Neurosciences, Multi-Organ Transplantation, Oncology, Gastro Sciences, Cardiac Sciences, Pulmonology, Interventional Radiology, Women & Children among others. The hospital will have state-of-the-art equipment and technology including PET, CT Scan, MRI, and ECMO. Additionally, it will have Cath Labs, Dialysis, Modular Operating Theatres, Ultrasound, Adult, Neonatal and Paediatric ICUs, as well as pharmacy and diagnostic facilities available 24 hours a day.

Speaking on the occasion, Dr. Azad Moopen, Founder Chairman and Managing Director of Aster DM Healthcare said, “Kasaragod has been facing a lot of challenges accessing good healthcare facilities over the last 3 years which resulted even in loss of lives. Our sixth hospital in Kerala will build upon our commitment to offering medical technology and treatment that is cutting-edge, allowing quality healthcare to be easily accessed for people in the area. Moreover, the expansion is part of our efforts to strengthen our presence in Kerala. The new hospital is in alignment with the organisation’s commitment to bridging the gap between urban and rural areas and make quality healthcare easily accessible for people.”

“With a history of over 35 years of care, our team of highly experienced experts will offer advanced treatments to patients using cutting-edge diagnostic and therapeutic technology. Once completed this will be one of the largest hospitals in the region. At Aster, we strive for excellence, every moment, and every day - to bring great healthcare within reach of people. We live by our motto We’ll Treat You well to the last detail.” said, Mr. Farhan Yasin, Regional Director, Aster- Kerala & Oman.

Aster DM Healthcare is committed to providing the highest quality of medical care to people and is at hand to fulfil all medical treatment, hospitalization, diagnostic and pharmacy needs for millions of patients in the MENA and the Asia Pacific regions. In a world where health problems and hospitals are multiplying by the day, Aster Hospital aims to make a difference, with its patient-centric approach to medical care. As a wholly patient-centric organization, Aster DM Healthcare has always been introducing global quality care protocols across its medical facilities in India which consists of 14 hospitals, 77 Aster branded pharmacies [1], Aster labs and clinics 

-Ends-

About Aster DM Healthcare

Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in GCC and in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary, and quaternary healthcare through our 27 hospitals, 126 clinics/ labs1 and over 300 pharmacies in seven countries, including India. We have over 22,000 plus dedicated staff including 3,029 doctors and 6,729 nurses across the geographies that we are present in, delivering a simple yet strong promise to our different stakeholders: “We’ll treat you well.” We reach out to all economic segments in the GCC states through our differentiated healthcare services across the “Aster”, “Medcare” and “Access” brands.

[1] In India, Aster Pharmacies are under brand license agreements.

For more information about us, please contact:
Lavanya Mandal                                                                                                   
Head of PR and Internal Communications                                          
Aster DM Healthcare
Email: lavanya.mandal@asterdmhealthcare.com
Rasheed Palliyalil
Watermelon Communications
Dubai, UAE
+9714 283 3655
Email: rasheed@watermelonme.com  

DISCLAIMER:

Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. Aster DM Healthcare will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2022

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.